Ascribe Bioscience Funding & Investors
Ithaca, NY
Ascribe Bioscience develops products that enable farmers to combat crop pathogens without negative impacts on the environment. The company is currently developing a seed treatment product that acts by boosting crops’ natural defenses. Ascribe Bioscience was founded in 2017 and is headquartered in Ithaca, New York.
ascribebio.comTotal Amount Raised: $19,159,996
Ascribe Bioscience Funding Rounds
Series A
$12,000,000
Series A Investors
Acre Venture PartnersCorteva CatalystCultivation CapitalSyngentaYield LabTrailhead CapitalSilver BlueSeed
$3,184,996
Seed Investors
Yield LabGrant
$500,000
Grant Investors
Grow-NYSeed
$2,500,000
Seed Investors
Acre Venture PartnersYield LabPonderosa VenturesTrailhead CapitalGrant
$750,000
Grant Investors
National Science FoundationGrant
$225,000
Grant Investors
National Science Foundation
Funding info provided by Diffbot.